MRKR

Marker Therapeutics INC

-$954.0K

Net Activity

Institutions Holding

35

Popularity Rank

#6870

Avg Weight

0.01%

Total Value

$5.1M

Ownership Trend

35 institutions currently hold MRKR, with 10 net buyers and 16 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Decreased

Based on recent trading activity

Net Selling Institutions

16

Net Buying Institutions

10

Key Holders

View all 35 holding institutions

Quarterly Activity

Recent Activity

+$661.4K

Total Buy Value

$1.1M

Total Sell Value

New buy4
Trim9
Add6
Sold out7

10

Net Buyers

16

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding MARKER THERAPEUTICS INC (MRKR)?
Major stakeholders currently include NEA Management Company, LLC ($2.1M), Blue Owl Capital Holdings LP ($720.5K), Vanguard Capital Management LLC ($506.1K). Based on the latest 13F filings, there are a total of 35 tracked investment funds and institutions maintaining positions in MRKR.
What is the overall institutional sentiment toward MRKR recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $954.0K, driven by 10 managers accumulating shares while 16 reduced their exposure.
Which institutions have been selling or reducing their MRKR positions?
In the latest period, 9 funds trimmed their holdings, and 7 managers completely exited their positions. The aggregate reported sell value was $1.1M.
Are there any notable investors adding MRKR to their portfolios?
Yes, buying activity remains notable. 4 institutions opened new positions in {ticker}, and 6 existing holders added to their shares. The total reported buy value for the quarter amounted to $661.4K.

Related Stocks